Metabolomics

Dataset Information

0

PGD2 and other lipid mediator changes in mouse adipose associated with administration of an oral inhibitor of H-PGDS (HQL-79)

ABSTRACT:

ORGANISM(S): Mus Musculus

TISSUE(S): Adipose Tissue

DISEASE(S): Obesity

PROVIDER: ST000593 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

Json Xml

Dataset's files

Source:
Action DRS
mwtab Other
Items per page:
1 - 1 of 1

Similar Datasets

Metabolomics PGD2 and other lipid mediator changes in mouse adipose associated with administration of an oral inhibitor of H-PGDS (HQL-79) (part II)
| ST000594 | MetabolomicsWorkbench
Unknown Prevention of Colitis-Associated Cancer via Oral Administration of M13-Loaded Lipid Nanoparticles.
| S-EPMC10534593 | biostudies-literature
Unknown Histologic analysis and lipid profiling reveal reproductive age-associated changes in peri-ovarian adipose tissue.
| S-EPMC6563378 | biostudies-literature
Unknown Oral Administration of <i>Latilactobacillus sakei</i> ADM14 Improves Lipid Metabolism and Fecal Microbiota Profile Associated With Metabolic Dysfunction in a High-Fat Diet Mouse Model.
| S-EPMC8527011 | biostudies-literature
Unknown Adipokinome Signatures in Obese Mouse Models Reflect Adipose Tissue Health and Are Associated with Serum Lipid Composition.
| S-EPMC6567124 | biostudies-literature
Unknown Castration-induced changes in mouse epididymal white adipose tissue.
| S-EPMC3867123 | biostudies-literature
Unknown Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism.
| S-EPMC11660827 | biostudies-literature
Unknown Radioiodine Exhalation Following Oral I-131 Administration in a Mouse Model.
| S-EPMC12025149 | biostudies-literature
Methylation profiling Longitudinal Methylomic changes in PTSD following Sub-Anaesthetic Oral Ketamine Administration
2026-01-17 | GSE287261 | GEO
Unknown Changes in lipid profiles of epileptic mouse model.
| S-EPMC10614666 | biostudies-literature